Diverse: Issues In Higher Education Launches Revamped Website Marking Nearly Half a Century of Publishing
17 nov. 2021 14h59 HE
|
Diverse Education
Fairfax, Va., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Diverse: Issues In Higher Education has revitalized its online platform – improving the visitor experience, increasing partner visibility and...
ImCheck Publishes Comprehensive Overview of the Development Results of Its First-in-class Cancer Immunotherapeutic Targeting BTN3A to Activate Vγ9Vδ2 T Cells in Science Translational Medicine
20 oct. 2021 14h21 HE
|
ImCheck Therapeutics SAS
ImCheck Publishes Comprehensive Overview of the DevelopmentResults of Its First-in-class Cancer Immunotherapeutic Targeting BTN3A to Activate Vγ9Vδ2 T Cellsin Science Translational Medicine ...
Learning from our Mistakes: Equipping Nations to Meet Biological Diversity Goals
28 janv. 2021 09h10 HE
|
NatureServe
Washington, DC, Jan. 28, 2021 (GLOBE NEWSWIRE) -- NatureServe’s Director of Biodiversity Indicators Program, Mike Gill, collaborated with researchers from China and Germany to complete a pivotal...
BioNTech veröffentlicht Daten zu neuartigem mRNA-Impfstoffansatz gegen Autoimmunkrankheiten in Science
07 janv. 2021 14h15 HE
|
BioNTech SE
Gemeinsame Studie von BioNTech, TRON und der Universitätsmedizin sowie dem Forschungszentrum für Immuntherapie der Johannes Gutenberg-Universität Mainz untersucht neuartigen entzündungshemmenden...
BioNTech Publishes Data on Novel mRNA Vaccine Approach to Treat Autoimmune Diseases in Science
07 janv. 2021 14h15 HE
|
BioNTech SE
Collaborative study of BioNTech with TRON and the University Medical Center and Research Center for Immunotherapy at Johannes Gutenberg University of Mainz introduces novel non-inflammatory mRNA...
Livanta Wins Highest Honor in 2020 MarCom Awards
28 oct. 2020 16h00 HE
|
Livanta LLC
ANNAPOLIS JUNCTION, Md., Oct. 28, 2020 (GLOBE NEWSWIRE) -- Livanta LLC announced today that the firm has been recognized internationally for excellence in the development of communications products...
Cyclacel’s Clinical Stage CDK2/9 Inhibitor Fadraciclib Targets Key Anti-Apoptotic and Oncogenic Pathways in Cancer
13 juil. 2020 07h00 HE
|
Cyclacel
-- Characterization of fadraciclib published in peer-reviewed journal shows specificity against CDK2 and CDK9 and enablement of apoptosis of cancer cells driven by MCL1, cyclin E and/or MYC – ...
RedHill Biopharma Announces Publication of Talicia® Pivotal Phase 3 Study Results in Annals of Internal Medicine
05 mai 2020 07h00 HE
|
RedHill Biopharma Ltd.
Talicia® is approved by the U.S. FDA and promoted by RedHill’s U.S. sales force--Abstract discussing Talicia pharmacokinetics and exposure-response presented as ePoster at Digestive Disease Week®...
Corbus Announces Publication of Lenabasum Systemic Sclerosis Double-Blind, Placebo-Control Phase 2 Clinical Trial Results in Arthritis & Rheumatology
29 avr. 2020 08h05 HE
|
Corbus Pharmaceuticals Holdings, Inc.
These previously presented data demonstrated lenabasum improved efficacy outcomes and underlying disease pathology compared to placebo and had an acceptable safety profile in Phase 2 studySystemic...
Cognition Therapeutics Announces Publication Analyzing Biomarkers of Synapse Damage or Loss to Support Future Therapeutic Development Efforts in Alzheimer's Disease
17 mars 2020 08h03 HE
|
Cognition Therapeutics, Inc.
New York, March 17, 2020 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., a clinical-stage neuroscience company focused on the protection and restoration of synaptic function in Alzheimer’s disease...